comprehensive
Previous article:
What does generative AI mean for health care? We asked experts
Next article: JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
Next article: JPM 2024: FogPharma’s CEO unveils ‘contrarian’ plan in oncology
Wikipedia
focus
-
Paxlovid study fails to answer questions over benefit for broader groups
2025-09-30 21:14 -
STAT's guide to the next generation of CAR
2025-09-30 20:55 -
Obesity experts on risks of Wegovy, Ozempic weight loss drugs
2025-09-30 20:02 -
As JPM 2024 winds down, some health tech firms project optimism
2025-09-30 19:45 -
The battle over the Brookhaven Landfill on Long Island
2025-09-30 19:44 -
Caregivers of transplant patients call for more support, training
2025-09-30 19:42